Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
CA 2389204 A1 · Owner: Commissariat A L'Energie Atomique · Inventors: Le Discorde, Magali; Prost, Stephane; Kirszenbaum, Marek
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a protein present at the surface of hematopoietic stem cells of the lymphoid cell line and mature NK cells the corresponding isolated cDNA sequence and their uses as marker of said cells and for preparing antibodies directed against said protein. The invention also concerns the uses of said antibodies for selecting cells expressing at their surface said protein. Said isolated protein has a structure (a) comprising an extracellular domain located between positions 21 and 152 five transmembrane domains located between positions 153 and 295 and a cytoplasmic domain located between positions 296 and 350 with reference to the sequence SEQ ID NO:2; an apparent molecular …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 10, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.